Lifeng Xu

Lifeng XU, was appointed vice president for Regulatory Affairs. Ms.Xu has 27 years’experience in product development, regulatory affairs and project management of vaccines, such as the preventive and therapeutic hepatitis B vaccine, MMR ( measles, mumps and rubella) vaccine, rabies vaccine and varicella vaccine, etc. Prior to joining CanSinoBIO, she held the position of deputy director of Research and Registration at CNBG. There she led her team in obtaining three new drug licenses and two CTAs. Before joining the bio-pharmaceutical industry, Ms.Xu earned a medical degree and worked at Chengde Hospital as an internist for 5 years.